213 related articles for article (PubMed ID: 17294285)
1. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices.
Bas Janssen MF; Birnie E; Bonsel GJ
Qual Life Res; 2007 Jun; 16(5):895-904. PubMed ID: 17294285
[TBL] [Abstract][Full Text] [Related]
2. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
Luo N; Johnson JA; Shaw JW; Coons SJ
Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three societally derived health-state classification values among older African Americans with depressive symptoms.
Jutkowitz E; Pizzi L; Hess E; Suh DC; Gitlin LN
Qual Life Res; 2013 Aug; 22(6):1491-8. PubMed ID: 22972437
[TBL] [Abstract][Full Text] [Related]
4. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
5. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
[TBL] [Abstract][Full Text] [Related]
6. A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A; Mayo NE
Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
[TBL] [Abstract][Full Text] [Related]
7. Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.
Conner-Spady BL; Marshall DA; Bohm E; Dunbar MJ; Loucks L; Al Khudairy A; Noseworthy TW
Qual Life Res; 2015 Jul; 24(7):1775-84. PubMed ID: 25555837
[TBL] [Abstract][Full Text] [Related]
8. Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population.
You R; Liu J; Yang Z; Pan C; Ma Q; Luo N
Health Qual Life Outcomes; 2020 Apr; 18(1):97. PubMed ID: 32272976
[TBL] [Abstract][Full Text] [Related]
9. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study.
Spronk I; Bonsel GJ; Polinder S; van Baar ME; Janssen MF; Haagsma JA
Burns; 2021 Jun; 47(4):873-879. PubMed ID: 33012569
[TBL] [Abstract][Full Text] [Related]
10. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.
Yfantopoulos JN; Chantzaras AE
Eur J Health Econ; 2017 May; 18(4):519-531. PubMed ID: 27262480
[TBL] [Abstract][Full Text] [Related]
11. The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample.
Luo N; Ko Y; Johnson JA; Coons SJ
Qual Life Res; 2009 Dec; 18(10):1377-85. PubMed ID: 19830593
[TBL] [Abstract][Full Text] [Related]
12. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.
Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
J Rheumatol; 2003 Oct; 30(10):2268-74. PubMed ID: 14528528
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.
Bosch JL; Hunink MG
Qual Life Res; 2000; 9(6):591-601. PubMed ID: 11236850
[TBL] [Abstract][Full Text] [Related]
15. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
16. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Yfantopoulos J; Chantzaras A; Kontodimas S
Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
[TBL] [Abstract][Full Text] [Related]
19. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample.
Nikl A; Janssen MF; Brodszky V; Rencz F
Health Qual Life Outcomes; 2023 Feb; 21(1):17. PubMed ID: 36803866
[TBL] [Abstract][Full Text] [Related]
20. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.
Luo N; Johnson JA; Shaw JW; Feeny D; Coons SJ
Med Care; 2005 Nov; 43(11):1078-86. PubMed ID: 16224300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
